TGFB1 and glioblastoma: demonstrated that CAR-NK targeting B7H3 of glioblastoma enhanced tumor lysis even with the presence of immunosuppressive TGF-β when co-expressing this CAR-NK with TGF-β dominant negative receptor (DNR) (105).